Maria-Teresa Ochoa1, 9, Steffen Stenger4, Peter A. Sieling1, Sybille Thoma-Uszynski1, Shereen Sabet1, Sungae Cho1, Alan M. Krensky5, Martin Rollinghoff4, Euzenir Nunes Sarno6, Anne E. Burdick7, Thomas H. Rea8
& Robert L. Modlin1, 2, 31
Division of Dermatology, University of California at Los Angeles School of Medicine, Los Angeles, California, USA
2
Department of Microbiology and Immunology, University of California at Los Angeles School of Medicine, Los Angeles, California, USA
3
Molecular Biology Institute, University of California at Los Angeles School of Medicine, Los Angeles, California, USA
4
Institute for Clinical Microbiology, Immunology and Hygiene, Universität Erlangen, Erlangen, Germany
5
Division of Immunology and Transplantation Biology, Deptartment of Pediatrics, Stanford University, Stanford, California, USA
6
Leprosy Laboratory Institute Oswaldo Cruz, Rio de Janeiro - RJ/Brasil
7
Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida, USA
8
Section of Dermatology, and University of Southern California School of Medicine, Los Angeles, California, USA
9
International Center for Medical Research and Training (CIDEIM), Cali, Colombia
10
M.-T.O., S.S. and P.A.S. contributed equally to this study.
Correspondence should be addressed to Robert L. Modlin rmodlin@mednet.ucla.edu
